Cuvposa FDA Approval History
FDA Approved: Yes (First approved July 28, 2010)
Brand name: Cuvposa
Generic name: glycopyrrolate
Dosage form: Oral Solution
Company: Shionogi Pharma Inc.
Treatment for: Chronic Drooling in Children
Cuvposa (glycopyrrolate) oral solution is an anticholinergic for the treatment of chronic severe drooling caused by neurologic disorders in children.
Development Timeline for Cuvposa
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.